Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,650,214
-$9,648 QoQ
Shares Held
5,935
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOKF, NA holds $12,079,082 across 17 Biotechnology names. VRTX ranks #1 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,935 | $2,650,214 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,331 | $2,416,036 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
53,892 | $2,172,385 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,351 | $1,043,835 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
14,954 | $966,476 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
19,585 | $484,924 | |
| 7 | INVA |
Innoviva, Inc.
|
20,328 | $473,641 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
1,829 | $472,467 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,650,214 | 5,935 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,659,862 | 5,867 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,756,361 | 7,038 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,674,680 | 8,254 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,442,221 | 7,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,135,018 | 7,785 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,652,272 | 7,853 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,751,165 | 8,003 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $4,277,078 | 10,232 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,936,795 | 19,506 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,817,789 | 19,606 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,760,893 | 19,212 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $6,295,413 | 19,981 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,681,791 | 23,138 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $1,977,557 | 6,830 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,946,604 | 6,908 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $3,020,988 | 11,576 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $2,544,724 | 11,588 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $2,364,055 | 13,033 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $3,615,523 | 16,825 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $9,933,133 | 42,029 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $11,846,199 | 43,533 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $14,115,742 | 48,623 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $11,601,013 | 48,754 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||